FDA
-
-
-
-
-
-
-
Abbott receives FDA approval for Volt heart rhythm treatment system
-
-
-
-
-
-
-
Oppenheimer Reiterates Outperform Rating on Abbott Labs (ABT)
-
-
-
-
-
-
-
Abbott Highlights New AVEIRâ„¢ Data, Initiates Trial for the Company's Conduction System Pacing Technology
-
-
-
-
-
-
-
RBC Capital: 'Opportunities Across MedTech Stocks'
-
-
-
-
-
-
-
Abbott Labs (ABT) PT Raised to $128 at Evercore ISI
-
-
-
-
-
-
-
Abbott Reports Second-Quarter 2024 Results and Raises Full-Year Guidance
-
-
-
-
-
-
-
Global Sports Nutrition Market Projected to Reach $78 Billion as Muscle Repair & Growth Becoming Vitally Important
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

